Insulin protects against hepatic damage postburn

Molecular Medicine

Volumn 17, Issue 5-6, 2011, Pages 516-522

  Jeschke, Marc G ^a,b,c,e   Kraft, Robert ^a,b   Song, Juquan ^a,b   Gauglitz, Gerd G ^a,f   Cox, Robert A ^a   Brooks, Natasha C ^c   Finnerty, Celeste C ^a,b   Kulp, Gabriela A ^a   Herndon, David N ^a,b   Boehning, Darren ^d  

^a Shriners Hospitals for Children   (United States)

^b UT Southwestern   (United States)

^c Departments of Biochemistry and Molecular Biology   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; INSULIN; INSULIN LANTUS; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY SURFACE; BURN; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; INFLAMMATION; LIVER CELL; LIVER INJURY; LIVER STRUCTURE; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTBURN; PRIORITY JOURNAL; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BURNS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOPLASMIC RETICULUM; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; INSULIN; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79957966856     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00166     Document Type: Article

References (36)

1. Bringham PA, McLoughlin E. (1996) Burn incidence and medical care use in the United States: estimates, trends and data sources. J. Burn Care Rehabil. 17:95-107.
2. Jeschke MG, et al. (2001) Cell proliferation, apo-ptosis, NF-kappaB expression, enzyme, protein, and weight changes in livers of burned rats. Am. J. Physiol. Gastrointest. Liver Physiol. 280:G1314-G13120.
3. Jeschke MG, Mlcak RP, Finnerty CC, Herndon DN. (2007) Changes in liver function and size after a severe thermal injury. Shock. 28:172-177.
4. Jeschke MG, et al. (2005) Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J. Hepatol. 42:870-879.
5. Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. (2004) Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann. Surg. 240:340-349.
6. Moshage H. (1997) Cytokines and the hepatic acute phase response. J. Pathol. 181:257-266.
7. Jeschke MG. (2009) The hepatic response to thermal injury: is the liver important for postburn outcomes? Mol. Med. 15:337-351.
8. Price LA, Thombs B, Chen CL, Milner SM. (2007) Liver disease in burn injury: evidence from a national sample of 31,338 adult patients. J. Burns Wounds. 7:e1.
9. Jeschke MG, Barrow RE, Herndon DN. (2004) Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch. Surg. 139:641-647.
10. Jeschke MG, Boehning DF, Finnerty CC, Hern-don DN. (2007) Effect of insulin on the inflammatory and acute phase response after burn injury. Crit. Care Med. 35:S519-S523.
11. Jeschke MG, et al. (2009) Calcium and ER stress mediate hepatic apoptosis after burn injury. J. Cell Mol. Med. 13:1857-1865.
12. Jeschke MG, et al. (2008) Pathophysiologic response to severe burn injury. Ann. Surg. 248:387-401.
13. Van den Berghe G, et al. (2006) Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354:449-461.
14. van den Berghe G, et al. (2001) Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345:1359-1367.
15. Jeschke MG, Klein D, Herndon DN. (2004) Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann. Surg. 239:553-560.
16. Jeschke MG, et al. (2010) Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am. J. Respir. Crit. Care Med. 182:351-359.
17. Jeschke MG, Einspanier R, Klein D, Jauch KW. (2002) Insulin attenuates the systemic inflammatory response to thermal trauma. Mol. Med. 8:443-450.
18. Herndon DN, Wilmore DW, Mason AD Jr. (1978) Development and analysis of a small animal model simulating the human postburn hyperme-tabolic response. J. Surg. Res. 25:394-403.
19. Gauglitz GG, et al. (2009) Post-burn hepatic insulin resistance is associated with ER stress. Shock. 2009, June 18 [Epub ahead of print].
20. Boehning D, et al. (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat. Cell Biol. 5:1051-1061.
21. Boehning D, Patterson RL, Snyder SH. (2004) Apoptosis and calcium: new roles for cy-tochrome c and inositol 1,4,5-trisphosphate. Cell Cycle. 3:252-254.
22. Boehning D, van Rossum DB, Patterson RL, Snyder SH. (2005) A peptide inhibitor of cy-tochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways. Proc. Natl. Acad. Sci. U. S. A. 102:1466-1471.
23. Wozniak AL, et al. (2006) Requirement of bipha-sic calcium release from the endoplasmic reticu-lum for Fas-mediated apoptosis. J. Cell Biol. 175:709-714.
24. Song J, Finnerty CC, Herndon DN, Boehning D, Jeschke MG. (2009) Severe burn-induced endo-plasmic reticulum stress and hepatic damage in mice. Mol. Med. 15:316-320.
25. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. (2008) Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery. 144:629-637.
26. Gauglitz GG, et al. (2009) Insulin increases resistance to burn wound infection-associated sepsis. Crit. Care Med. 38:202-208.
27. Ron D, Walter P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol. Cell. Biol. 8:519-529.
28. Hampton RY. (2000) ER stress response: getting the UPR hand on misfolded proteins. Curr. Biol. 10:R518-R521.
29. Mori K. (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell. 101:451-454.
30. Ozcan U, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 306:457-461.
31. Ozcan U, et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 313:1137-1140.
32. White MF. (1997) The insulin signalling system and the IRS proteins. Diabetologia. 40 Suppl 2:S2-S17.
33. Kahn CR, et al. (1993) The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Prog. Horm. Res. 48:291-339.
34. Le Roith D, Zick Y. (2001) Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care. 24:588-597.
35. Gauglitz GG, Herndon DN, Jeschke MG. (2008) Insulin resistance postburn: underlying mechanisms and current therapeutic strategies. J. Burn Care Res. 29:683-694.
36. Aguirre V, Uchida T, Yenush L, Davis R, White MF. (2000) The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275:9047-9054.